Medicare Enrolled
Dr. Peter Honig, DO
Family Medicine - Adult · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Honig from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Honig?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Honig
Dr. Peter Honig is a family medicine - adult specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Honig performed 4,358 Medicare services across 2,440 unique beneficiaries.
Between the years covered by Open Payments, Dr. Honig received a total of $150,263 from 87 pharmaceutical and/or device companies across 2128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine - adult. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Honig is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in PA
$150,263 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,358
Medicare services
Top 6% in PA for family medicine - adult
2,440
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~218 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
1,385 | $59 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
710 | $95 | $165 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
266 | $136 | $200 |
| Annual depression screening | 245 | $20 | $25 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
233 | $27 | $50 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
173 | $62 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
160 | $68 | $110 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
150 | $29 | $35 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
138 | $72 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
121 | $8 | $20 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
94 | $89 | $135 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
91 | $70 | $130 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
81 | $41 | $65 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
62 | $93 | $200 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
59 | $152 | $250 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
56 | $233 | $350 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
45 | $140 | $220 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
28 | $3 | $22 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
24 | $11 | $35 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
24 | $29 | $35 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
23 | $282 | $300 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
23 | $51 | $90 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $54 | $165 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
21 | $128 | $200 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
21 | $30 | $80 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $11 | $75 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
17 | $1 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $128 | $269 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
15 | $174 | $250 |
| Recombinant quadrivalent influenza vaccine A flu shot that protects against four strains of influenza virus. It is produced using recombinant DNA technology rather than growing the virus in eggs. |
14 | $72 | $80 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
12 | $16 | $80 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $172 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$150,263
Total received (2018-2024)
Avg $21,466/year across 7 years
Top 0% in PA for family medicine - adult
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
2,128
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$61,609 (41.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61,252 (40.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,402 (18.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$28,447
2023
$34,639
2022
$11,298
2021
$8,881
2020
$14,813
2019
$27,739
2018
$24,446
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$17,052
ABBVIE INC.
$6,280
AstraZeneca UK Limited
$1,020
Lilly USA, LLC
$350
Novo Nordisk Inc
$343
Bayer Healthcare Pharmaceuticals Inc.
$325
GlaxoSmithKline, LLC.
$251
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$224
Otsuka America Pharmaceutical, Inc.
$204
Boehringer Ingelheim Pharmaceuticals, Inc.
$199
Novartis Pharmaceuticals Corporation
$183
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$182
PFIZER INC.
$149
Amgen Inc.
$136
Corcept Therapeutics
$120
Biogen, Inc.
$113
Gilead Sciences, Inc.
$111
Sumitomo Pharma America, Inc.
$96
SHIELD THERAPEUTICS INC
$91
Janssen Pharmaceuticals, Inc
$91
Alkermes, Inc.
$90
Astellas Pharma US Inc
$84
Collegium Pharmaceutical, Inc.
$77
Merck Sharp & Dohme LLC
$68
Lundbeck LLC
$60
SANOFI-AVENTIS U.S. LLC
$56
Esperion Therapeutics, Inc.
$55
Kowa Pharmaceuticals America, Inc.
$50
Abbott Laboratories
$46
AIMMUNE THERAPEUTICS, INC.
$45
IDORSIA PHARMACEUTICALS US INC
$43
IRONWOOD PHARMACEUTICALS, INC
$42
Xeris Pharmaceuticals, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$36
Hologic Sales and Service, LLC
$34
E.R. Squibb & Sons, L.L.C.
$27
SANOFI PASTEUR INC.
$25
IBSA Pharma Inc.
$20
Inari Medical, Inc.
$15
Phathom Pharmaceuticals, Inc.
$14
Top 3 companies account for 85.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$69,556
Janssen Pharmaceuticals, Inc
$20,598
PFIZER INC.
$15,452
ABBVIE INC.
$7,491
Novo Nordisk Inc
$3,792
AstraZeneca AB
$3,262
Allergan Inc.
$2,510
Allergan, Inc.
$2,413
GlaxoSmithKline, LLC.
$2,329
Daiichi Sankyo Inc.
$1,802
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,414
AbbVie, Inc.
$1,326
Lilly USA, LLC
$1,249
SANOFI-AVENTIS U.S. LLC
$1,106
Takeda Pharmaceuticals U.S.A., Inc.
$1,054
AstraZeneca UK Limited
$1,020
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,002
Amgen Inc.
$922
Novartis Pharmaceuticals Corporation
$849
Bayer Healthcare Pharmaceuticals Inc.
$755
Astellas Pharma US Inc
$633
AbbVie Inc.
$548
Merck Sharp & Dohme Corporation
$523
Lundbeck LLC
$509
Amarin Pharma Inc.
$485
Bayer HealthCare Pharmaceuticals Inc.
$406
Kowa Pharmaceuticals America, Inc.
$354
Otsuka America Pharmaceutical, Inc.
$353
Gilead Sciences, Inc.
$342
OptiNose US, Inc.
$333
Abbott Laboratories
$318
Mallinckrodt Enterprises LLC
$310
Mallinckrodt Hospital Products Inc.
$296
Esperion Therapeutics, Inc.
$267
Optinose US, Inc.
$266
IDORSIA PHARMACEUTICALS US INC
$256
E.R. Squibb & Sons, L.L.C.
$246
Sumitomo Pharma America, Inc.
$200
Merck Sharp & Dohme LLC
$191
Ironwood Pharmaceuticals, Inc
$187
Corcept Therapeutics
$182
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$182
ITI, Inc.
$171
Alkermes, Inc.
$154
Galderma Laboratories, L.P.
$150
Teva Pharmaceuticals USA, Inc.
$138
Axsome Therapeutics, Inc.
$135
NESTLE HEALTHCARE NUTRITION INC.
$132
Biohaven Pharmaceutical Holding Company Ltd.
$131
Biogen, Inc.
$130
Eisai Inc.
$128
Regeneron Healthcare Solutions, Inc.
$125
IRONWOOD PHARMACEUTICALS, INC
$104
Hikma Pharmaceuticals USA
$98
SHIELD THERAPEUTICS INC
$91
Circassia Pharmaceuticals Inc
$90
Xeris Pharmaceuticals, Inc.
$89
Nestle HealthCare Nutrition Inc.
$77
Collegium Pharmaceutical, Inc.
$77
SANOFI PASTEUR INC.
$71
Horizon Therapeutics plc
$69
West-Ward Pharmaceuticals
$66
IBSA Pharma Inc.
$62
Bausch Health US, LLC
$61
UCB, Inc.
$61
Sunovion Pharmaceuticals Inc.
$61
Iroko Pharmaceuticals, LLC
$54
Mylan Specialty L.P.
$49
AIMMUNE THERAPEUTICS, INC.
$45
ARBOR PHARMACEUTICALS, INC.
$42
Hologic Sales and Service, LLC
$34
SCILEX PHARMACEUTICALS INC.
$29
ViiV Healthcare Company
$25
Scilex Pharmaceuticals Inc.
$24
Ardelyx, Inc.
$20
Shield Therapeutics Inc
$19
HeartFlow, Inc.
$18
Arbor Pharmaceuticals, Inc.
$17
Eyevance Pharmaceuticals LLC
$16
Medtronic, Inc.
$16
Inari Medical, Inc.
$15
Phathom Pharmaceuticals, Inc.
$14
Mallinckrodt LLC
$14
INSYS Therapeutics Inc
$13
Intra-Sana Laboratories
$13
Zyla Life Sciences
$13
Purdue Pharma L.P.
$12
Top 3 companies account for 70.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · APTIMA · AREXVY · Aimovig · Auvelity · BELSOMRA · BEVESPI AEROSPHERE · BOTOX - MIGRAINE · BREZTRI · BREZTRI AEROSPHERE · BRINTELLIX · BROVANA · BYDUREON · BYSTOLIC · Belbuca · Briviact · CAMZYOS · CAPLYTA · CHANTIX · COMIRNATY · CREON · Creon · DIFICID · DOVATO · DUAKLIR PRESSAIR · DUEXIS · Dayvigo · Descovy · Dexilant · Dymista · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · FARXIGA · FASENRA · FFRct · FLOWTRIEVER CATHETER · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GATTEX · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · Horizant · IBSRELA · INJECTAFER · INVOKAMET · INVOKANA · Infinity DBS Pulse Generators · JANUVIA · JARDIANCE · Kerendia · Kloxxado · Korlym · LEQVIO · LICART · LINZESS · LIVALO · LOKELMA · LONHALA MAGNAIR · LYBALVI · LYRICA · Linzess · Livalo · MINIMED 770G · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NEXLETOL · NUCALA · NURTEC ODT · OFEV · OXYCONTIN · Otezla · Ozempic · PAXLOVID · PENNSAID · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RAYOS · RELTONE 200 MG · REXULTI · RYBELSUS · Repatha · Rybelsus · S · SEGLENTIS · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SPINRAZA · SPIRIVA · SPIRIVA RESPIMAT · SPRIX · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNDROS · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TUDORZA PRESSAIR · TZIELD · Tirosint · Tobradex ST · Tresiba · Trintellix · UBRELVY · Uloric · VERQUVO · VIBERZI · VIVLODEX · VOQUEZNA · VOWST · VRAYLAR · VYVANSE · Vascepa · Vemlidy · Veozah · Victoza · Vimpat · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xhance · ZENPEP · ZORYVE · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (41%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for family medicine - adult in PA.
Geographic Context
Family medicine - adults within 10 mi
55
Per 100K population
3.5
County median income
$60,698
Nearest hospital
MALVERN BEHAVIORAL HEALTH
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Honig is a clinical cardiology specialist, with above-average Medicare volume (top 6% in PA), with consulting-driven industry engagement in the top 0% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Honig experienced with nursing facility visit, low complexity?
Based on Medicare claims data, Dr. Honig performed 1,385 nursing facility visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Honig receive payments from pharmaceutical companies?
Yes. Dr. Honig received a total of $150,263 from 87 companies across 2,128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Honig's costs compare to other family medicine - adults in Philadelphia?
Dr. Honig's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Honig) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Family Medicine - Adults in Philadelphia
Browse family medicine - adults in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine - Adults in PA
Family medicine - adults ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine - Adults in PA
Which PA family medicine - adults receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology